EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Serum amyloid A as a diagnostic marker for histologic chorioamnionitis in preterm premature rupture of membranes: A diagnostic accuracy study

Azam Faraji, Mitra Mehraban, Maryam Kasraeian, Mojgan Akbarzadeh-Jahromi, Homeira Vafaei, Nasrin Asadi, Zahra Oveisi, Marzieh Kasraie, Marjan Zare

International Journal of Reproductive BioMedicine (IJRM) · 17.05.2026 · 24 (3)

DOI: 10.18502/ijrm.v24i3.21115 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Reproductive BioMedicine (IJRM), online erschienen am 17.05.2026. Verfasst von Azam Faraji und 8 weiteren Autor:innen. Beteiligte Einrichtung: Maternal-Fetal Medicine Research Center, Department of Obstetrics and Gynecology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, …. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Chorioamnionitis is an acute inflammation of the fetal membrane in mothers with preterm premature rupture of the membrane (PPROM). The diagnosis of chorioamnionitis is based on clinical findings; however, laboratory tests may help diagnose the disease.

Objective

It aimed to evaluate the accuracy of maternal serum-amyloid A (SAA) protein levels in diagnosing histopathologic chorioamnionitis following PPROM mothers; secondarily, it assessed their accuracy for diagnosing clinical chorioamnionitis. Materials and Methods: In this diagnostic accuracy study, 94 PPROM pregnancies, referred to Namazi, Hafez, and Zeinabiyeh hospitals, Shiraz, Iran, from March 2022 to March 2023 were followed. All placentas were examined for histopathological evidence of chorioamnionitis, and participants were classified into 2 pathologic chorioamnionitis and normal placenta groups.

Results

From the 94 participants, 50 (43.20%) were pathologically diagnosed with chorioamnionitis as pathologic chorioamnionitis group, and the remaining 44 (46.80%) belonged to control “normal placenta group”. In addition, 50% (25/50) of women with pathological chorioamnionitis were clinically diagnosed with chorioamnionitis as clinic chorioamnionitis group, and the remaining 50% (25/50) with no clinical signs of chorioamnionitis belonged to their control. Pathologic at-delivery SAA were more in the pathologic chorioamnionitis group compared with normal placenta group; adjusted odds ratio (95% confidence interval); 15.20 (2.62–88.20); the area under curve values (cutoff point, sensitivity, specificity, negative predictive value, positive predictive value, and accuracy) were 0.83 (> 0.54 mg/dl, 95%, 70%, 86%, 88%, and 84%) for pathologic at-delivery SAA. However, clinic at-delivery SAA did not significantly change between clinic chorioamnionitis group and not having clinic chorioamnionitis. A no-clinic chorioamnionitis PPROM mother could be chorioamnionitis one by a 50% chance, even with no clinical sign.

Conclusion

Pathologic at-delivery SAA level could be a supplementary test in PPROM mothers. At-delivery SAA serial measurements and long-term evaluation of infants born to these mothers are recommended.

Schlagwörter

Stichwörter der Autor:innen

ChorioamnionitisFetal membranesPremature rupture.Serum amyloid A protein

Autor:innen und Institutionen

  • Maternal-Fetal Medicine Research Center, Department of Obstetrics and Gynecology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
  • Maternal-Fetal Medicine Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
  • Department of Public Health, Khalkhal University of Medical Sciences, Khalkhal, Iran.

Zitieren

APA

Faraji, A., Mehraban, M., Kasraeian, M., Akbarzadeh-Jahromi, M., Vafaei, H., Asadi, N., Oveisi, Z., Kasraie, M., & Zare, M. (2026). Serum amyloid A as a diagnostic marker for histologic chorioamnionitis in preterm premature rupture of membranes: A diagnostic accuracy study. International Journal of Reproductive BioMedicine (IJRM), 24(3). https://doi.org/10.18502/ijrm.v24i3.21115

Vancouver

Faraji A, Mehraban M, Kasraeian M, Akbarzadeh-Jahromi M, Vafaei H, Asadi N, et al. Serum amyloid A as a diagnostic marker for histologic chorioamnionitis in preterm premature rupture of membranes: A diagnostic accuracy study. International Journal of Reproductive BioMedicine (IJRM). 2026;24(3). doi:10.18502/ijrm.v24i3.21115

BibTeX
@article{Faraji2026,
  author = {Faraji, Azam and Mehraban, Mitra and Kasraeian, Maryam and Akbarzadeh-Jahromi, Mojgan and Vafaei, Homeira and Asadi, Nasrin and Oveisi, Zahra and Kasraie, Marzieh and Zare, Marjan},
  title = {Serum amyloid A as a diagnostic marker for histologic chorioamnionitis in preterm premature rupture of membranes: A diagnostic accuracy study},
  journal = {International Journal of Reproductive BioMedicine (IJRM)},
  year = {2026},
  volume = {24},
  number = {3},
  doi = {10.18502/ijrm.v24i3.21115}
}
Kostenlos starten →